I'm loving the effort the company is putting towards its investor relations in the presentations etc.
The AGM presentation today is yet another perfect example.
Slide 5 - The top-27 shareholders own 70% of the company - this provides an extremely sticky shareholder base.
Slide 7 - The number of shareholders has grown significantly from c. 800 to c. 1300 since August when the 'shareholder awareness' program really started as the company began its commercialisation / business development activities.
I've maintained for a long time, the greater the share markets awareness of ALC - the higher the SP will be. The investment case is extremely compelling & we are still a fair way off of fair value. (By my methodology - see the ALC-Valuation thread - currently 18.5c)
Tomorrow will see more institutional investor exposure for the company and these guys will slot straight in to the top-20 shareholding list should they also feel the investment case is compelling. Note that these guys are "actively looking for ehealth exposure" and are there in an "invite only" capacity.
I have never been involved with a company that has such a focus on it's shareholder base in every major presentation. It is extremely refreshing as management are certainly on the ball & acutely aware of what it takes to generate a sustainable >100m mkt cap company. That is, not only having a great product that is well received in the market place, but being sensitive to the shareholders mindset.
We are only at the beginning of this journey & there are certainly very exciting things to come!
- Forums
- ASX - By Stock
- ALC - New Beginnings
I'm loving the effort the company is putting towards its...
-
- There are more pages in this discussion • 166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALC (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.89M |
Open | High | Low | Value | Volume |
5.7¢ | 5.9¢ | 5.7¢ | $21.49K | 372.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 518145 | 5.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.0¢ | 164942 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 518145 | 0.058 |
1 | 82955 | 0.057 |
7 | 612459 | 0.056 |
8 | 1499929 | 0.055 |
6 | 340892 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 164942 | 2 |
0.061 | 169190 | 2 |
0.062 | 144347 | 2 |
0.063 | 50322 | 2 |
0.064 | 43238 | 1 |
Last trade - 15.59pm 10/10/2024 (20 minute delay) ? |
Featured News
ALC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online